Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Burke, Crystal W ^a   Mason, John N ^a   Surman, Sherri L ^a   Jones, Bart G ^a   Dalloneau, Emilie ^a   Hurwitz, Julia L ^a   Russell, Charles J ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BIOLUMINESCENCE; CONTROLLED STUDY; DONOR; ILLUMINATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LUNG INFECTION; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS INFECTION; RECIPIENT; SENDAI VIRUS; TRACHEITIS; UPPER RESPIRATORY TRACT INFECTION; VIRAL TROPISM; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CYTOLOGY; DISEASE COURSE; DISEASE TRANSMISSION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUMINESCENCE; LUNG; LUNG LAVAGE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; RESPIROVIRUS INFECTION; RODENT DISEASE; TRACHEA; VIROLOGY;

ANIMALIA; MURINAE; MUS; PARAINFLUENZA VIRUS; SENDAI VIRUS;

ADMINISTRATION, INTRANASAL; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; DISEASE PROGRESSION; LUCIFERASES; LUMINESCENT MEASUREMENTS; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYSTEM; RESPIROVIRUS INFECTIONS; RODENT DISEASES; SENDAI VIRUS; TRACHEA;

EID: 79960943611     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002134     Document Type: Article

References (87)

1. Karron RA, Collins PL, eds. (2007) Parainfluenza Viruses. 5 ed Philadelphia Lippincott, Williams and Wilkins pp. 1497-1526.
2. Lamb RA, Parks GD, eds. (2007) Paramyxoviridae: The Viruses and Their Replication. 5 ed Philadelphia Lippincott, Williams and Wilkins pp. 1449-1496.
3. Williams JV, Edwards KM, Weinberg GA, Griffin MR, Hall CB, et al. (2010) Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 201: 1890-1898.
4. Chanock RM, Parrott RH, Johnson KM, Kapikian AZ, Bell JA, (1963) Myxoviruses: Parainfluenza. Am Rev Respir Dis 88: S152-S166.
5. Parrott RH, Vargosko AJ, Kimhw, Bell JA, Chanock RM, (1962) Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses. Am J Public Health Nations Health 52: 907-917.
6. Parrott RH, Vargosko A, Luckey A, Kim HW, Cumming C, et al. (1959) Clinical features of infection with hemadsorption viruses. N Engl J Med 260: 731-738.
7. Murphy BR, Collins PL, (2002) Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. J Clin Invest 110: 21-27.
8. Moscona A, (2005) Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest 115: 1688-1698.
9. Schaap-Nutt A, Scull MA, Schmidt AC, Murphy BR, Pickles RJ, (2010) Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys. Vaccine 28: 2788-2798.
10. Nagai Y, (1999) Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev Med Virol 9: 83-99.
11. Faisca P, Desmecht D, (2007) Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date. Res Vet Sci 82: 115-125.
12. Denny FW, Murphy TF, Clyde WA Jr, Collier AM, Henderson FW, (1983) Croup: an 11-year study in a pediatric practice. Pediatrics 71: 871-876.
13. Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, et al. (2005) Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunol 18: 255-266.
14. Dave VP, Allan JE, Slobod KS, Smith FS, Ryan KW, et al. (1994) Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Virology 199: 376-383.
15. Hurwitz JL, Soike KF, Sangster MY, Portner A, Sealy RE, et al. (1997) Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15: 533-540.
16. Sangster M, Hyland L, Sealy R, Coleclough C, (1995) Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments. Virology 207: 287-291.
17. Slobod KS, Shenep JL, Lujan-Zilbermann J, Allison K, Brown B, et al. (2004) Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine 22: 3182-3186.
18. Jones B, Zhan X, Mishin V, Slobod KS, Surman S, et al. (2009) Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. Vaccine 27: 1848-1857.
19. Zhan X, Hurwitz JL, Krishnamurthy S, Takimoto T, Boyd K, et al. (2007) Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine 25: 8782-8793.
20. Zhan X, Slobod KS, Krishnamurthy S, Luque LE, Takimoto T, et al. (2008) Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine 26: 3480-3488.
21. Iida T, (1972) Experimental study on the transmission of Sendai virus in specific pathogen-free mice. J Gen Virol 14: 69-75.
22. van der Veen J, Poort Y, Birchfield DJ, (1970) Experimental transmission of Sendai virus infection in mice. Arch Gesamte Virusforsch 31: 237-246.
23. Hall CB, (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344: 1917-1928.
24. Henrickson KJ, (2003) Parainfluenza viruses. Clin Microbiol Rev 16: 242-264.
25. Sealy R, Jones BG, Surman SL, Hurwitz JL, (2010) Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. Vaccine 28: 6749-6756.
26. Rudraraju R, Surman S, Jones B, Sealy R, Woodland DL, et al. (2011) Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut. Virology 410: 429-436.
27. Luker KE, Luker GD, (2008) Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res 78: 179-187.
28. Hasan MK, Kato A, Shioda T, Sakai Y, Yu D, et al. (1997) Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J Gen Virol 78 (Pt 11): 2813-2820.
29. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, et al. (2010) Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107: 11531-11536.
30. Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL, (2006) Nonsegmented negative-strand viruses as vaccine vectors. J Virol 80: 10293-10306.
31. Griesenbach U, Meng C, Farley R, Cheng SH, Scheule RK, et al. (2008) In vivo imaging of gene transfer to the respiratory tract. Biomaterials 29: 1533-1540.
32. Tokusumi T, Iida A, Hirata T, Kato A, Nagai Y, et al. (2002) Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus Res 86: 33-38.
33. Kato A, Kiyotani K, Hasan MK, Shioda T, Sakai Y, et al. (1999) Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene. J Virol 73: 9237-9246.
34. Southam DS, Dolovich M, O'Byrne PM, Inman MD, (2002) Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 282: L833-839.
35. Mo XY, Sarawar SR, Doherty PC, (1995) Induction of cytokines in mice with parainfluenza pneumonia. J Virol 69: 1288-1291.
36. Tashiro M, Pritzer E, Khoshnan MA, Yamakawa M, Kuroda K, et al. (1988) Characterization of a pantropic variant of Sendai virus derived from a host range mutant. Virology 165: 577-583.
37. Miyamae T, (2005) Differential invasion by Sendai virus of abdominal parenchymal organs and brain tissues in cortisone- and cyclophosphamide-based immunosuppressed mice. J Vet Med Sci 67: 369-377.
38. Kiyotani K, Sakaguchi T, Fujii Y, Yoshida T, (1993) F0-containing noninfectious Sendai virus can initiate replication in mouse lungs but requires a relatively long incubation period. J Virol 67: 7618-7622.
39. Reichelderfer TE, Chanock RM, Craighead JE, Huebner RJ, Turner HC, et al. (1958) Infection of human volunteers with type 2 hemadsorption virus. Science 128: 779-780.
40. Brownstein DG, (1987) Resistance/susceptibility to lethal Sendai virus infection genetically linked to a mucociliary transport polymorphism. J Virol 61: 1670-1671.
41. Brownstein DG, Smith AL, Johnson EA, (1981) Sendai virus infection in genetically resistant and susceptible mice. Am J Pathol 105: 156-163.
42. Brownstein DG, Winkler S, (1986) Genetic resistance to lethal Sendai virus pneumonia: virus replication and interferon production in C57BL/6J and DBA/2J mice. Lab Anim Sci 36: 126-129.
43. Faisca P, Anh DB, Desmecht DJ, (2005) Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains. Am J Physiol Lung Cell Mol Physiol 289: L777-787.
44. Hall CB, Douglas RG Jr, (1981) Modes of transmission of respiratory syncytial virus. J Pediatr 99: 100-103.
45. McLean DM, Bannatyne RM, Givan KF, (1967) Myxovirus dissemination by air. Can Med Assoc J 96: 1449-1453.
46. Lowen AC, Mubareka S, Steel J, Palese P, (2007) Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3: 1470-1476.
47. Anderson DE, von Messling V, (2008) Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression. J Virol 82: 10510-10518.
48. Luque LE, Bridges OA, Mason JN, Boyd KL, Portner A, et al. (2010) Residues in the heptad repeat A region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol 84: 810-821.
49. Bousse T, Matrosovich T, Portner A, Kato A, Nagai Y, et al. (2002) The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction. J Virol 76: 8244-8251.
50. Spriggs MK, Collins PL, (1986) Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. J Virol 59: 646-654.
51. Rassa JC, Parks GD, (1998) Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5. Virology 247: 274-286.
52. Cattaneo R, Rebmann G, Baczko K, ter Meulen V, Billeter MA, (1987) Altered ratios of measles virus transcripts in diseased human brains. Virology 160: 523-526.
53. Touzelet O, Loukili N, Pelet T, Fairley D, Curran J, et al. (2009) De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene. Virus Res 140: 40-48.
54. von Messling V, Milosevic D, Cattaneo R, (2004) Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 101: 14216-14221.
55. Rudd PA, Cattaneo R, von Messling V, (2006) Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 80: 9361-9370.
56. Lemon K, de Vries RD, Mesman AW, McQuaid S, van Amerongen G, et al. (2011) Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7: e1001263.
57. de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, et al. (2007) Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3: e178.
58. Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, et al. (2005) Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79: 1113-1124.
59. Villenave R, Touzelet O, Thavagnanam S, Sarlang S, Parker J, et al. (2010) Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells. J Virol 84: 11718-11728.
60. Hall CB, Douglas RG Jr, Schnabel KC, Geiman JM, (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 33: 779-783.
61. Parrott RH, Kim HW, Brandt CD, Chanock RM, (1975) Potential of attenuated respiratory syncytial virus vaccine for infants and children. Dev Biol Stand 28: 389-399.
62. Tyrrell DA, Bynoe ML, Petersen KB, Sutton RN, Pereira MS, (1959) Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1). Br Med J 2: 909-911.
63. Stephens HA, (2010) HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338: 99-114.
64. Zhang L, Katz JM, Gwinn M, Dowling NF, Khoury MJ, (2009) Systems-based candidate genes for human response to influenza infection. Infect Genet Evol 9: 1148-1157.
65. Arkwright PD, Abinun M, (2008) Recently identified factors predisposing children to infectious diseases. Curr Opin Infect Dis 21: 217-222.
66. Simon AY, Moritoh K, Torigoe D, Asano A, Sasaki N, et al. (2009) Multigenic control of resistance to Sendai virus infection in mice. Infect Genet Evol 9: 1253-1259.
67. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, et al. (2009) Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83: 10417-10426.
68. Anh DB, Faisca P, Desmecht DJ, (2006) Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am J Physiol Lung Cell Mol Physiol 291: L426-435.
69. Itoh T, Iwai H, Ueda K, (1991) Comparative lung pathology of inbred strain of mice resistant and susceptible to Sendai virus infection. J Vet Med Sci 53: 275-279.
70. Stark JM, McDowell SA, Koenigsknecht V, Prows DR, Leikauf JE, et al. (2002) Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J Med Virol 67: 92-100.
71. Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, et al. (1992) Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 267: 13573-13579.
72. Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, et al. (1992) Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol 66: 7211-7216.
73. Zurcher C, Burek JD, Van Nunen MC, Meihuizen SP, (1977) A naturally occurring epizootic caused by Sendai virus in breeding and aging rodent colonies. I. Infection in the mouse. Lab Anim Sci 27: 955-962.
74. Profeta ML, Lief FS, Plotkin SA, (1969) Enzootic sendai infection in laboratory hamsters. Am J Epidemiol 89: 316-324.
75. Bhatt PN, Jonas AM, (1974) An epizootic of Sendai infection with mortality in a barrier-maintained mouse colony. Am J Epidemiol 100: 222-229.
76. Ishida N, Homma M, (1978) Sendai virus. Adv Virus Res 23: 349-383.
77. Nakagawa M, Saito M, Kinoshita K, Suzuki E, Imaizumi K, (1980) Pathogenicity of Sendai virus in mice cage-mated with infectors and their offsprings. Nippon Juigaku Zasshi 42: 337-344.
78. Sakaguchi T, Kiyotani K, Sakaki M, Fujii Y, Yoshida T, (1994) A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains. Arch Virol 135: 159-164.
79. Itoh M, Isegawa Y, Hotta H, Homma M, (1997) Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J Gen Virol 78 (Pt 12): 3207-3215.
80. Kiyotani K, Sakaguchi T, Fujii Y, Yoshida T, (2001) Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells. Arch Virol 146: 893-908.
81. Garcin D, Itoh M, Kolakofsky D, (1997) A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology 238: 424-431.
82. Fujii Y, Sakaguchi T, Kiyotani K, Huang C, Fukuhara N, et al. (2002) Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA. J Virol 76: 8540-8547.
83. Sakaguchi T, Kiyotani K, Watanabe H, Huang C, Fukuhara N, et al. (2003) Masking of the contribution of V protein to Sendai virus pathogenesis in an infection model with a highly virulent field isolate. Virology 313: 581-587.
84. Skiadopoulos MH, Surman SR, Riggs JM, Elkins WR, St Claire M, et al. (2002) Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees. Virology 297: 153-160.
85. Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T, (2006) Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Res 121: 23-32.
86. Skiadopoulos MH, Surman SR, Riggs JM, Orvell C, Collins PL, et al. (2002) Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins. Virology 297: 136-152.
87. Luque LE, Russell CJ, (2007) Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein. J Virol 81: 3130-3141.